Current and emerging novel immunotherapies for myeloma HMP Education 21:57 6 years ago 116 Далее Скачать
What non-cellular immunotherapies are in development for multiple myeloma? Multiple Myeloma Hub 3:07 4 years ago 153 Далее Скачать
Can novel immunotherapies cure multiple myeloma? VJHemOnc – Video Journal of Hematology & HemOnc 3:41 3 years ago 3 531 Далее Скачать
Is treatment discontinuation feasible for patients with myeloma with deep and durable responses? VJHemOnc – Video Journal of Hematology & HemOnc 1:40 2 years ago 82 Далее Скачать
How do I treat patients who have relapsed after quadruplet regimen in the first-line in MM? Multiple Myeloma Hub 8:18 1 month ago 269 Далее Скачать
Is there an optimal time to deploy immunotherapies in multiple myeloma? Multiple Myeloma Hub 3:54 4 years ago 97 Далее Скачать
Defining and identifying ultra-high-risk multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:11 10 months ago 448 Далее Скачать
Why GPRC5D is a promising target for multiple myeloma Multiple Myeloma Hub 2:43 3 years ago 345 Далее Скачать
Roundtable discussion—Multiple Myeloma Hub Satellite Symposium: Should 'cure' be the goal for MM? Multiple Myeloma Hub 27:15 3 years ago 121 Далее Скачать
What are the most promising CAR T therapies in development for multiple myeloma? Multiple Myeloma Hub 4:11 5 years ago 452 Далее Скачать
How to decide between bispecific antibodies or CAR T-cell therapies Multiple Myeloma Hub 8:31 4 years ago 283 Далее Скачать
Could radiotherapeutic approaches be a promising new treatment option for myeloma? Multiple Myeloma Hub 3:15 4 years ago 625 Далее Скачать
Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MD Dana-Farber Cancer Institute 37:46 2 years ago 1 954 Далее Скачать
What are the key differences between bispecific antibodies and CAR T cells? Multiple Myeloma Hub 3:03 3 years ago 147 Далее Скачать
Daratumumab as maintenance therapy for transplant-eligible patients with NDMM: What have we learn... Multiple Myeloma Hub 13:25 2 years ago 155 Далее Скачать
In which scenarios a PI added to Rd maintenance could benefit patients with MM after auto-HSCT? Multiple Myeloma Hub 4:37 2 years ago 67 Далее Скачать
The PROMISE study: What have we learnt about MGUS prevalence and clinical implications? Multiple Myeloma Hub 3:36 2 years ago 1 275 Далее Скачать
Should 'cure' be the goal for multiple myeloma? Multiple Myeloma Hub 28:10 2 years ago 97 Далее Скачать
The future of arginine deprivation therapy in lung cancer VJOncology 1:36 1 year ago 466 Далее Скачать